Skip to main content

TuHURA Biosciences, Inc.

HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001498382

No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding TuHURA Biosciences, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of HURA: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders7065−5
Shares6.14M6.45M+316.3K (+5.2%)
Value$15.2M$4.88M−$10.3M (−67.8%)

New holders (7)

Institutions that held TuHURA Biosciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to HURA in Q4 2025
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc39,093$29.6K0.00%
Journey Strategic Wealth LLC10,009$7.57K0.00%
Hodges Capital Management Inc.10,000$7.57K0.00%
CWA Asset Management Group, LLC10,000$7.57K0.00%
GAMMA Investing LLC341$2580.00%
International Assets Investment Management, LLC100$760.00%
Allworth Financial LP3$30.00%

Sold out (12)

Institutions that held TuHURA Biosciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of HURA in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Brighton Jones LLC27,735$68.8K
Creative Planning23,094$57.3K
LPL Financial LLC22,895$56.8K
SG Americas Securities, LLC16,608$41.0K
Virtu Financial LLC10,340$26.0K
SRS Capital Advisors, Inc.1,551$3.85K
Groupe la Francaise357$751
Fortitude Family Office, LLC208$516
Nisa Investment Advisors, LLC205$508
Clearstead Advisors, LLC131$325
Godsey & Gibb Associates10$25
XTX Topco Ltd17,793$0